Clinical Trial Update: A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the pharmacokinetic interaction between vemurafenib and a single dose of tizanidine in patients with BRAFV600 mutation–positive met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• TIZANIDINE (TIZANIDINE)
• Vemurafenib (vemurafenib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma, Neoplasms | Phase 1 | Status: COMPLETED